CBIO down a bit here,all solid and currently trading Half of it's Cash on hand,link back.
2.44 cash/share+ solid balance sheet+ high ownership for a micro cap company+ solid news past week+ Pfizer has an agreement with Catalyst. Solid reasons for me stay long.
CBIO OXGN and SPEX trading Under $20m cap,have healthy balance sheet,combined w/solid Former and Upcoming Catalysts w/impressive risk/reward ratios imo: